Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, the concentration of plasma arginine vasopressin (AVP) and
substance P
(SP) in normotensive subjects as well as patients with essential hypertension was measured. The results showed that: (1) The concentration of plasma AVP in patients with essential hypertension (21.83 +/- 1.30ng/L) was significantly higher than that in normotensive subjects (11.02 +/- 1.05 ng/L) (P < 0.001). The level of plasma SP in hypertensive subjects (276.60 +/- 21.35 pmol/L) was obviously lower than that in normotensive subjects (958.20 +/- 31.13 pmol/L) (P < 0.001). (2) The level of plasma AVP decreased (from 24.88 +/- 1.63 to 8.69 +/- 1.39 ng/L, P < 0.001) and that of plasma SP increased (from 331.40 +/- 48.18 to 958.80 +/- 39.30 pmol/L, P < 0.001) after antihypertensive drug treatment. (3) A negative correlation was found between the level of plasma AVP and SP in patients with essential hypertension (r = -0.564, P < 0.001), but no correlation was found between them in normotensive subjects (r = -0.096, P > 0.05). It is suggested that the abnormal level of plasma AVP and SP plays a role in the pathogenesis of hypertension.
Zhonghua
Nei
Ke Za Zhi 1993 May
PMID:[The role of arginine-vasopressin and substance P in the pathogenesis of hypertension and their interrelation]. 750 32
Non-adrenergic non-cholinergic (NANC) nerves are the third nervous system in the lung. There are increasing evidences that the main transmitters of NANC inhibitory (NANC-i) nerves and NANC excitatory (NANC-e) nerves are vasoactive intestinal peptide (VIP) and
substance P
(SP) respectively. We measured the levels of plasma VIP. SP and bronchial responsiveness in the patients with asthma. Chronic bronchitis and healthy subjects. The results showed that VIP level is decreased and negatively correlated with airway resistance, whereas SP level is increased and positively correlated with bronchial hyperresponsiveness (BHR) in asthma. It is suggested that overexcitation of NANC-e nerves and deficiency of NANC-i nerves are closely related with asthma attack and BHR.
Zhonghua
Nei
Ke Za Zhi 1993 Mar
PMID:[A clinical study on the effect of non-adrenergic non-cholinergic nerves in asthma]. 751 57
In order to clarify the pathogenesis of hemorrhagic fever with renal syndrome (HFRS), we detected HFRS virus structural proteins expressed in perepheral blood mononuclear cells (PBMC) by using immunohistochemical technique. Meanwhile we also determined plasma endothelin (ET),
substance P
(SP) and some sensitive markers of renal function with radioimmunoassay. The result showed that in HFRS patients, from the day of admission up to the thirteenth day of illness, the antigens of HFRS virus membrane protein (MP) and nucleocapsid (NP) could simultaneously be found in PBMC, though their expressive degree gradually decreased when the condition of the patients became better. Based on the external appearance and nucleus pattern of PBMC we recognized the MP and NP positive cells were mainly monocytes among which only a few presented faint IgM and C3 stain. On admission there was difference in expressive intensity between MP and NP. The MP expressive intensity was in parallel with plasma ET/SP ratio, the general condition and the severity of renal damage. These data suggest that HFRS virus can invade PBMC, replicate in them, and express their structural proteins. MP may be related with the pathogenesis of HFRS virus and the increase of plasma ET/SP ratio may be an important factor aggravating kidney injury.
Zhonghua
Nei
Ke Za Zhi 1996 Jul
PMID:[A study on the pathogenetic role of the viral structural proteins of hemorrhagic fever with renal syndrome]. 959 17
Nausea and vomiting are 2 of the most upsetting adverse reactions of chemotherapy. Current guidelines propose 5-hydroxytryptamine3 (5-HT3) receptor antagonists as a pharmacologic intervention for acute and delayed nausea and vomiting [chemotherapy-induced nausea and vomiting (CINV)] associated with moderately and highly emetogenic chemotherapy. Meanwhile, both postoperative nausea and vomiting (PONV) and postdischarge nausea and vomiting are challenging situations after surgeries and procedures. Prophylactic and therapeutic combinations of antiemetics are recommended in patients at high risk of suffering from PONV and postdischarge nausea and vomiting. Granisetron (Kytril) is a selective 5-HT3 receptor antagonist that does not induce or inhibit the hepatic cytochrome P-450 system in vitro. There are also 4 other antagonists of 5-HT3 receptor (dolasetron, ondansetron, palonosetron, and tropisetron) being metabolized via the CYP2D6 and are subject to potential genetic polymorphism. The launch of a new class of antiemetics, the
substance P
/neurokinin1 receptor antagonists, was attributed to the scientific update on the central generator responsible for emesis and role of
substance P
. There has been mounting interest in exploring integrative medicine, either acupuncture or acustimulation of P6 (
Nei
-Kuwan), to complement the western medicine for prevention and management of nausea and vomiting. The potential application of cannabinoids, either alone or in combination with other agents of different mechanism, could contribute further to improve outcome in CINV. Implementation of future treatment guidelines for more effective management of CINV and PONV could certainly improve the efficacy and outcome of cancer and postoperative care.
...
PMID:A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. 2084 45